|Articles|April 20, 2020
Ripple Science Announces Initiatives During COVID-19
Advertisement
Ripple Science has announced new initiatives to help clinical researchers continue their research during this uncertain time by giving research teams free access to Ripple for their first study. For those working on COVID-19 trials directly, the company is providing six-months of access free of charge.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Subcutaneous Saphnelo Shows Positive Phase III Results in Systemic Lupus Erythematosus
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
